{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Toronto",
      "state": "N/A",
      "country": "Canada",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74361",
      "recalling_firm": "Attix Pharmaceuticals Inc",
      "address_1": "481 University Ave Unit 502",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "CO",
      "recall_number": "D-1047-2016",
      "product_description": "Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada",
      "product_quantity": "N/A",
      "reason_for_recall": "cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration",
      "recall_initiation_date": "20160518",
      "center_classification_date": "20160621",
      "termination_date": "20160726",
      "report_date": "20160629",
      "code_info": "Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017"
    }
  ]
}